EMERGO THERAPEUTICS, INC.

Profile

Company Names

EMERGO THERAPEUTICS, INC.

Addresses

6208 FAYETTEVILLE ROAD #104, DURHAM, NC 27713

Phone Numbers

919-599-4381

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$16,024,137.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2022-04-26 
$500,000.00 
$1,500,000.00 
$1,000,000.00 
Debt 
2
2020-10-09 
$3,524,137.00 
$5,024,352.00 
$1,500,215.00 
Equity 
1
2018-05-22 
$12,000,000.00 
$12,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
E. 
BAILEY, JR. 
DIRECTOR
EMERGO THERAPEUTICS, INC.
JOHN E. 
 
BAILEY, JR. 
DIRECTOR
EMERGO THERAPEUTICS, INC.
ROBERT 
 
HELMEDAG 
DIRECTOR
PHYND TECHNOLOGIES, INC.   |  EMERGO THERAPEUTICS, INC.   |  LEGACY VENTURES, LLC
ROBIN 
 
HYDE-DERUYSCHER 
EXECUTIVE OFFICER
EMERGO THERAPEUTICS, INC.
MOISE 
 
KHAYRALLAH 
EXECUTIVE OFFICER, DIRECTOR
NEURONEX, INC.   |  SOLAS PHARMA, LLC   |  AERIAL BIOPHARMA, LLC   |  TARGET PHARMASOLUTIONS, INC.   |  EMERGO THERAPEUTICS, INC.
MARGARET 
 
POWELL 
DIRECTOR
TARGET PHARMASOLUTIONS, INC.   |  EMERGO THERAPEUTICS, INC.   |  BIO 54, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-05-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2022-04-26 
2020-10-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-09 
2019-09-19
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#